S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
Log in
NASDAQ:TOCA

Tocagen Stock Forecast, Price & News

$38.99
-0.03 (-0.08 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$38.71
Now: $38.99
$40.00
50-Day Range
$1.26
MA: $32.15
$41.03
52-Week Range
$0.42
Now: $38.99
$6.77
Volume28,189 shs
Average Volume1.47 million shs
Market Capitalization$932.60 million
P/E RatioN/A
Dividend YieldN/A
Beta0.01
Tocagen Inc., a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to deliver therapeutic genes into the DNA of cancer cells. The company's lead product candidate is Toca 511 & Toca FC that is under Phase III clinical trial for recurrent high-grade glioma. It is also developing Toca 511 & Toca FC in a Phase Ib clinical trial for intravenous treatment of advanced cancers. In addition, the company is developing other RRVs to deliver genes to cancer cells against validated immunotherapy targets. The company has a license agreement with ApolloBio to develop and commercialize Toca 511 & Toca FC; and a collaboration agreement with NRG Oncology to develop a clinical trial utilizing Toca 511 & Toca FC for the treatment of patients with newly diagnosed glioblastoma. Tocagen Inc. was founded in 2007 and is based in San Diego, California.
Tocagen logo

MarketRank

Overall MarketRank

0.83 out of 5 stars

Medical Sector

1103rd out of 1,925 stocks

Pharmaceutical Preparations Industry

515th out of 773 stocks

Analyst Opinion: 1.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TOCA
CUSIPN/A
Phone858-412-8400
Employees77

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$40,000.00
Price / Sales23,315.05
Book Value$0.45 per share

Profitability

Net Income$-63,520,000.00
Net Margins-176,433.34%

Miscellaneous

Market Cap$932.60 million
Next Earnings DateN/A
OptionableOptionable
$38.99
-0.03 (-0.08 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TOCA News and Ratings via Email

Sign-up to receive the latest news and ratings for TOCA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tocagen (NASDAQ:TOCA) Frequently Asked Questions

How has Tocagen's stock price been impacted by COVID-19 (Coronavirus)?

Tocagen's stock was trading at $1.55 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TOCA shares have increased by 2,415.5% and is now trading at $38.99.
View which stocks have been most impacted by COVID-19
.

Is Tocagen a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tocagen in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Tocagen stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TOCA, but not buy additional shares or sell existing shares.
View analyst ratings for Tocagen
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Tocagen?

Wall Street analysts have given Tocagen a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Tocagen wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Tocagen's CEO?

1,448 employees have rated Tocagen CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Tocagen's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

How were Tocagen's earnings last quarter?

Tocagen Inc (NASDAQ:TOCA) posted its earnings results on Thursday, April, 23rd. The company reported ($0.43) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.44) by $0.01. Tocagen had a negative return on equity of 327.74% and a negative net margin of 176,433.34%.
View Tocagen's earnings history
.

What price target have analysts set for TOCA?

1 brokers have issued 1-year target prices for Tocagen's stock. Their forecasts range from $1.00 to $1.00. On average, they expect Tocagen's stock price to reach $1.00 in the next year. This suggests that the stock has a possible downside of 97.4%.
View analysts' price targets for Tocagen
or view Wall Street analyst' top-rated stocks.

Who are some of Tocagen's key competitors?

What other stocks do shareholders of Tocagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tocagen investors own include Selecta Biosciences (SELB), Inovio Pharmaceuticals (INO), VBI Vaccines (VBIV), SCYNEXIS (SCYX), Catalyst Pharmaceuticals (CPRX), T2 Biosystems (TTOO), Amarin (AMRN), Novavax (NVAX), OPKO Health (OPK) and Amicus Therapeutics (FOLD).

Who are Tocagen's key executives?

Tocagen's management team includes the following people:
  • Mr. Martin J. Duvall, CEO & Director (Age 57)
  • Mr. Thomas E. Darcy, Co-Founder & Director (Age 68)
  • Dr. Douglas J. Jolly, Co-Founder and Exec. VP of Research & Pharmaceutical Devel. (Age 71)
  • Mr. Mark G. Foletta C.P.A., CPA, Exec. VP & CFO (Age 58)
  • Dr. Harry E. Gruber, Founder, Adviser & Director (Age 66)

When did Tocagen IPO?

(TOCA) raised $80 million in an IPO on Thursday, April 13th 2017. The company issued 7,300,000 shares at a price of $10.00-$12.00 per share. Leerink Partners, Evercore ISI and Stifel served as the underwriters for the IPO.

What is Tocagen's stock symbol?

Tocagen trades on the NASDAQ under the ticker symbol "TOCA."

How do I buy shares of Tocagen?

Shares of TOCA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tocagen's stock price today?

One share of TOCA stock can currently be purchased for approximately $38.99.

How big of a company is Tocagen?

Tocagen has a market capitalization of $932.60 million and generates $40,000.00 in revenue each year. The company earns $-63,520,000.00 in net income (profit) each year or ($2.69) on an earnings per share basis. Tocagen employs 77 workers across the globe.

What is Tocagen's official website?

The official website for Tocagen is www.tocagen.com.

How can I contact Tocagen?

Tocagen's mailing address is 4242 CAMPUS POINT COURT SUITE 500, SAN DIEGO CA, 92121. The company can be reached via phone at 858-412-8400 or via email at [email protected]advisors.com.

This page was last updated on 1/23/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.